Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Drug Delivery

Read more breaking news


News in brief

Prokarium to create new oral vaccine delivery tech

Last updated on 11-Jul-2012 at 13:43 GMT2012-07-11T13:43:20Z

Prokarium – a biotech company that was formerly part of UK CMO Cobra Biologics spin-out - has bought an oral vaccine technology from Emergent BioSolutions.

The platform includes is a live Salmonella-based typhoid vaccine Typhella and genetic technology spi-VEC developed by Emergent. Prokarium will combine this with its own ORT-vac expression platform to create an oral vaccine delivery platform, named Vaxonella.

Prokarium plans to license the delivery platform to other biotechnology companies, while its in-house team will use it to develop a dual oral vaccine against typhoid and travellers’ diarrhoea.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...